
Quick answer: Pregabalin and gabapentin are both gabapentinoids. They bind the same target, the α2δ subunit of voltage-gated calcium channels. The key difference is absorption. Pregabalin is absorbed predictably (bioavailability of 90% or more at every dose) and peaks in about 1 hour. Gabapentin's absorption saturates, so the share absorbed falls from about 60% at 900 mg/day to about 27% at 4800 mg/day, and it peaks in 2 to 3 hours.
For registered medical practitioners, pharmacists and pharma professionals. Educational information, not medical advice. Both are prescription medicines.
Why this question comes up so often
Pharmacists and doctors regularly ask why one gabapentinoid is chosen over the other when both act on nerve pain. The answer lies less in the target and more in pharmacokinetics: how reliably each drug gets from the stomach into the bloodstream.
Same target: the α2δ subunit
Both drugs are structurally related to GABA, but neither acts on GABA receptors. They bind the α2δ subunit of voltage-gated calcium channels in nerve cells. This reduces calcium entry into overactive nerve endings and lowers the release of excitatory neurotransmitters, which is why both are used in neuropathic pain conditions.
The real difference: absorption
Gabapentin is absorbed through a transporter in the small intestine that becomes saturated as the dose rises. According to the US prescribing information, its bioavailability is about 60% at 900 mg/day, 47% at 1200 mg/day, 34% at 2400 mg/day, 33% at 3600 mg/day and 27% at 4800 mg/day, given in three divided doses. In practice, four times the dose does not deliver four times the drug to the blood.
Pregabalin follows linear kinetics. Its bioavailability stays at 90% or more across its clinical dose range, so blood levels rise in proportion to the dose.
| Gabapentin daily dose | Approx. bioavailability |
|---|---|
| 900 mg/day | 60% |
| 1200 mg/day | 47% |
| 2400 mg/day | 34% |
| 3600 mg/day | 33% |
| 4800 mg/day | 27% |
Pregabalin vs gabapentin at a glance
| Feature | Gabapentin | Pregabalin |
|---|---|---|
| Target | α2δ subunit of voltage-gated calcium channels | α2δ subunit of voltage-gated calcium channels |
| Kinetics | Non-linear (saturable absorption) | Linear |
| Bioavailability | About 60% falling to 27% as dose rises | 90% or more, dose-independent |
| Time to peak level | 2 to 3 hours | About 1 hour |
| Half-life | 5 to 7 hours | About 6 hours |
| Usual dosing frequency | Three times daily | Two or three times daily |
| Time to effective dose with titration | About 14 days | About 5 to 7 days |
| Elimination | Kidneys, unchanged | Kidneys, unchanged |
| Renal impairment | Dose adjustment needed | Dose adjustment needed |
Myths vs facts
- Myth: Pregabalin is just a stronger gabapentin. Fact: They share a mechanism. The practical difference is how predictably each reaches the blood.
- Myth: They work on GABA receptors. Fact: Neither does. Both bind the α2δ subunit.
- Myth: Kidney function does not matter. Fact: Both are cleared unchanged by the kidneys, so doses are adjusted in renal impairment.
What every pharmacy team should know
- Prescription only. Dispense both only against a valid prescription.
- Common effects. Dizziness, drowsiness and swelling of the feet. Patients should be careful driving until they know how they react.
- Do not stop suddenly. Labels advise tapering gradually, over at least a week.
- Misuse potential. Watch for early or repeated refill requests. Responsible dispensing protects patients.
Key takeaway
Pregabalin and gabapentin share a target but not a pharmacokinetic profile. Pregabalin's linear, near-complete absorption makes its blood levels more predictable, while gabapentin's saturable absorption means higher doses give diminishing returns. Treatment choice remains the decision of the treating doctor.
FAQs
What is the main difference between pregabalin and gabapentin?
Both bind the α2δ subunit of voltage-gated calcium channels. Pregabalin is absorbed linearly with bioavailability of 90% or more and peaks in about 1 hour; gabapentin absorption saturates, falling from about 60% to 27% as the daily dose rises, and it peaks in 2 to 3 hours.
Do pregabalin and gabapentin act on GABA receptors?
No. Despite being structurally related to GABA, neither acts on GABA receptors.
Do they need dose adjustment in kidney disease?
Yes. Both are eliminated largely unchanged by the kidneys, so doses are adjusted in renal impairment.
Can either be stopped suddenly?
Labels advise tapering gradually over at least a week. Any change should be made by the prescriber.
Are they prescription medicines?
Yes. Both are sold only on the prescription of a registered medical practitioner.
Sources
- Gabapentin, US prescribing information (oral bioavailability by dose).
- Bockbrader HN et al. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49(10):661-669.
- Pregabalin pharmacokinetics compared with gabapentin. Ther Adv Drug Saf. 2014;5(1):38-56.
- Comparison of pharmacokinetics and dosage of gabapentinoids. Br J Pain. 2020;14(2):104-114.
About the author: Saurav Thakur is Business Head at Eridanus Healthcare.
About Eridanus Healthcare: Eridanus Healthcare (Est. 2012) is an Indian pharmaceutical company focused on Neuropsychiatry/CNS, with 300+ products across CNS, Ortho, Gastro, Antibiotics and General Medicine, manufactured at WHO-GMP partner facilities. This article is part of the CNS Insights series for healthcare professionals.




